Interferon-γ drives T reg fragility to promote anti-tumor immunity
RNA-seq (gene expression) · mouse · 45 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 45 samples: 18 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE97939_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA383402 and SRA study SRP104179. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 45 samples.
How we read this: 18 replicated groups read from 45 sample titles; they account for 45 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM2582006 HNG_2 HNG
- GSM2582007 HNG_3 HNG
- GSM2582008 HNG_ds1 HNG_ds
- GSM2582009 HNG_ds2 HNG_ds
- GSM2582010 HNG_rep4 HNG
- GSM2582011 HNY_2 HNY
- GSM2582012 HNY_3 HNY
- GSM2582013 HNY_ds1 HNY_ds
- GSM2582014 HNY_ds2 HNY_ds
- GSM2582015 HNY_rep4 HNY
- GSM2582016 HTG_2 HTG
- GSM2582017 HTG_3 HTG
- GSM2582018 HTG_ds1 HTG_ds
- GSM2582019 HTG_ds2 HTG_ds
- GSM2582020 HTG_rep4 HTG
- GSM2582021 HTY_2 HTY
- GSM2582022 HTY_3 HTY
- GSM2582023 HTY_ds1 HTY_ds
- GSM2582024 HTY_ds2 HTY_ds
- GSM2582025 HTY_rep4 HTY
- GSM2582026 NN_2 NN
- GSM2582027 NN_3 NN
- GSM2582028 NN_ds1 NN_ds
- GSM2582029 NN_ds2 NN_ds
- GSM2582030 NN_rep4 NN
- GSM2582031 NT_2 NT
- GSM2582032 NT_3 NT
- GSM2582033 NT_ds1 NT_ds
- GSM2582034 NT_ds2 NT_ds
- GSM2582035 NT_rep4 NT
- GSM2582036 TE_2 TE
- GSM2582037 TE_3 TE
- GSM2582038 TE_ds1 TE_ds
- GSM2582039 TE_ds2 TE_ds
- GSM2582040 TE_rep4 TE
- GSM2582041 WN_2 WN
- GSM2582042 WN_3 WN
- GSM2582043 WN_ds1 WN_ds
- GSM2582044 WN_ds2 WN_ds
- GSM2582045 WN_rep4 WN
+ 5 more — browse all 45 samples with per-sample file links →
- GSE295483 Type-I interferon priming signal balances anti-bacterial and anti-tumor trained immunity in alveolar macrophages [RNA-seq] 19 samples shares interferon, anti-tumor, immunity
- GSE333386 PARK7-Mediated Delactylation of SF3B Reprograms RNA Splicing to Attenuate Fibrosis and Promote Anti-Tumor Immunity 9 samples shares anti-tumor, immunity, promote
- GSE297709 STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity 18 samples shares interferon, anti-tumor, immunity
- GSE324687 Eomes sustains progenitor CD4⁺ T helper cells to promote anti-tumor immunity during immunotherapy [scRNA] 16 samples shares anti-tumor, immunity, promote
- GSE278990 Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity 73 samples shares anti-tumor, immunity
- GSE322775 Coordinated immune activation following KRAS inhibition reveals molecular pathways that potentiate and limit anti-tumor immunity 47 samples shares anti-tumor, immunity
- GSE289723 Interleukin-4 modulates type I interferon to augment anti-tumour immunity [scRNA-Seq] 36 samples shares interferon, immunity
- GSE278980 Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity - RNA-seq of C57BL/6 murine models 32 samples shares anti-tumor, immunity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.